Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Musk Praises Grok for Dominating AI Day Trading Competition: We Will Do Better

Musk Praises Grok for Dominating AI Day Trading Competition: We Will Do Better

BlockBeatsBlockBeats2026/02/09 06:35

BlockBeats News, February 9th, Musk retweeted a tweet praising Grok's overwhelming performance in the AI Coining Competition Alpha Arena, "We need to do better, and we will."


Currently, Grok 4.20 is completely dominating Alpha Arena, with a return rate soaring from about 12% to close to 35% within 10 days, ranking first on the leaderboard, with a higher return rate than any other model on the list, and all different variants of Grok are profitable. Grok currently holds 4 out of the top 6 positions on the leaderboard, with GPT-5.1 - 4 MAX in second place and DEEPSEEK-CHAT-V3.1 in third place among the top six.


BlockBeats Note: The Alpha Arena competition is a competition where AI models engage in real-time trading in the cryptocurrency market, trading perpetual contracts with real funds on platforms like Hyperliquid.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

华尔街见闻•2026/10/26 05:56
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.